LacriFill Canalicular Filler for Dry Eye Syndrome

MH
Overseen ByMelissa Hamann Wright, Study Staff
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Mann Eye Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is a single-site, prospective, randomized (2:1) controlled study of subjects aged 18-39 who are candidates for bilateral LASIK and have dry eye symptoms (OSDI ≥13). The LacriFill group (n=50) receives bilateral lower canalicular LacriFill placement within 7 days prior to surgery plus standard postoperative care; the control group (n=25) receives standard postoperative care only. The primary outcome is the change in Ocular Surface Disease Index (OSDI) score from baseline to 3 months after bilateral LASIK.

Who Is on the Research Team?

PB

Phillip Brunson, OD

Principal Investigator

Mann Eye Institute

Are You a Good Fit for This Trial?

This trial is for adults aged 18-39 who are planning to have LASIK surgery on both eyes and already have symptoms of dry eye. Participants must meet a certain score on a dry eye questionnaire.

Inclusion Criteria

Able to complete study visits
OSDI ≥13
BCDVA 20/20 or better
See 3 more

Exclusion Criteria

I have had eye surgery before.
Pregnancy
Principal investigator may declare patient ineligible or non-evaluable based on medical evidence indicating unsuitability for the trial
See 5 more

What Are the Treatments Tested in This Trial?

Interventions

  • LacriFill Canalicular Filler

Trial Overview

The study compares two groups: one gets a LacriFill canalicular filler in the lower eyelids before LASIK plus standard care, while the other receives only standard postoperative care. The main goal is to see if LacriFill improves dry eye symptoms after surgery.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: LacriFill GroupExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mann Eye Institute

Lead Sponsor

Trials
3
Recruited
110+

Sengi

Industry Sponsor

Trials
28
Recruited
2,100+